| Hafiz Rizwan Talib Hashmi, MD | |
|
855 A Ave Ne Ste 400, Cedar Rapids, IA 52402-5064 | |
| (718) 960-1234 | |
| Not Available |
| Full Name | Hafiz Rizwan Talib Hashmi |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 7 Years |
| Location | 855 A Ave Ne Ste 400, Cedar Rapids, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558674176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD-44231 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital | Cedar rapids, IA | Hospital |
| Allen Hospital | Waterloo, IA | Hospital |
| Mercy Medical Center - Cedar Rapids | Cedar rapids, IA | Hospital |
| Jones Regional Medical Center | Anamosa, IA | Hospital |
| Compass Memorial Healthcare | Marengo, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allen Memorial Hospital Corporation | 4284546045 | 99 |
| Iowa Physicians Clinic Medical Foundation | 8729992318 | 972 |
News Archive
Researchers at Yale shed new light on the mechanism of nerve cell growth by identifying novel functions for a molecular "motor" protein, myosin-II, according to an article in Nature Cell Biology.
Æterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported that the 043 Thorough QT (TQT) trial, which is part of the cetrorelix pamoate clinical development program in benign prostatic hyperplasia (BPH), met its primary endpoint.
March is National Nutrition Month, the time when dietitians and other health professionals encourage all of us to pay attention to what we eat. This annual call to action to make informed food choices is even more important for growing kids and teens.
In the midst of the nation's current healthcare reform controversy, third-year Tulane University medical students are completing their clerkships in both rural and urban areas, and, increasingly, in community settings
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that the John Wayne Cancer Institute in Santa Monica, California has opened enrollment in a Phase I clinical study with MORAb-028 in patients with advanced melanoma.
› Verified 8 days ago
| Entity Name | Iowa Physicians Clinic Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366425274 PECOS PAC ID: 8729992318 Enrollment ID: O20031118000363 |
News Archive
Researchers at Yale shed new light on the mechanism of nerve cell growth by identifying novel functions for a molecular "motor" protein, myosin-II, according to an article in Nature Cell Biology.
Æterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported that the 043 Thorough QT (TQT) trial, which is part of the cetrorelix pamoate clinical development program in benign prostatic hyperplasia (BPH), met its primary endpoint.
March is National Nutrition Month, the time when dietitians and other health professionals encourage all of us to pay attention to what we eat. This annual call to action to make informed food choices is even more important for growing kids and teens.
In the midst of the nation's current healthcare reform controversy, third-year Tulane University medical students are completing their clerkships in both rural and urban areas, and, increasingly, in community settings
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that the John Wayne Cancer Institute in Santa Monica, California has opened enrollment in a Phase I clinical study with MORAb-028 in patients with advanced melanoma.
› Verified 8 days ago
| Entity Name | Allen Memorial Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891772927 PECOS PAC ID: 4284546045 Enrollment ID: O20031211000480 |
News Archive
Researchers at Yale shed new light on the mechanism of nerve cell growth by identifying novel functions for a molecular "motor" protein, myosin-II, according to an article in Nature Cell Biology.
Æterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported that the 043 Thorough QT (TQT) trial, which is part of the cetrorelix pamoate clinical development program in benign prostatic hyperplasia (BPH), met its primary endpoint.
March is National Nutrition Month, the time when dietitians and other health professionals encourage all of us to pay attention to what we eat. This annual call to action to make informed food choices is even more important for growing kids and teens.
In the midst of the nation's current healthcare reform controversy, third-year Tulane University medical students are completing their clerkships in both rural and urban areas, and, increasingly, in community settings
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that the John Wayne Cancer Institute in Santa Monica, California has opened enrollment in a Phase I clinical study with MORAb-028 in patients with advanced melanoma.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hafiz Rizwan Talib Hashmi, MD 855 A Ave Ne Ste 400, Cedar Rapids, IA 52402-5064 Ph: (319) 363-3565 | Hafiz Rizwan Talib Hashmi, MD 855 A Ave Ne Ste 400, Cedar Rapids, IA 52402-5064 Ph: (718) 960-1234 |
News Archive
Researchers at Yale shed new light on the mechanism of nerve cell growth by identifying novel functions for a molecular "motor" protein, myosin-II, according to an article in Nature Cell Biology.
Æterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported that the 043 Thorough QT (TQT) trial, which is part of the cetrorelix pamoate clinical development program in benign prostatic hyperplasia (BPH), met its primary endpoint.
March is National Nutrition Month, the time when dietitians and other health professionals encourage all of us to pay attention to what we eat. This annual call to action to make informed food choices is even more important for growing kids and teens.
In the midst of the nation's current healthcare reform controversy, third-year Tulane University medical students are completing their clerkships in both rural and urban areas, and, increasingly, in community settings
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that the John Wayne Cancer Institute in Santa Monica, California has opened enrollment in a Phase I clinical study with MORAb-028 in patients with advanced melanoma.
› Verified 8 days ago
Chirantan Ghosh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1951 51st St Ne, Cedar Rapids, IA 52402 Phone: 319-294-1899 Fax: 319-294-1773 | |
Leon L Qiao, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 931 8th Ave Se, Cedar Rapids, IA 52401 Phone: 319-366-8695 Fax: 319-366-0795 | |
Boothapuri Venkatesh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 202 10th St Se, Suite 225, Cedar Rapids, IA 52403 Phone: 319-364-7101 Fax: 319-363-1993 | |
Harinder Singh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 202 10th St Se, Cedar Rapids, IA 52403 Phone: 319-398-1546 | |
Hisham Wagdy, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 202 10th St Se, Suite 225, Cedar Rapids, IA 52403 Phone: 319-364-7101 Fax: 319-363-1993 | |
Deborah W Wilbur, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 10th St Se, Hpcc 3rd Floor, Cedar Rapids, IA 52403 Phone: 319-363-8303 Fax: 319-364-4659 | |
Dr. Wei Li, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 543 7th St Se, Cedar Rapids, IA 52401 Phone: 319-861-7600 |